de Boer J, Thornton AR Neural correlates of perceptual learning in the auditory brainstem: efferent activity predicts and reflects improvement at a speech-in-noise discrimination task. J Neurosci. 2008 May 7;28(19):4929-37. doi: 10.1523/JNEUROSCI.0902-08.2008.
Goodman SS, Mertes IB, Lewis JD, Weissbeck DK Medial olivocochlear-induced transient-evoked otoacoustic emission amplitude shifts in individual subjects. J Assoc Res Otolaryngol. 2013 Dec;14(6):829-42. doi: 10.1007/s10162-013-0409-9. Epub 2013 Aug 28.
Guinan JJ Jr Olivocochlear efferents: anatomy, physiology, function, and the measurement of efferent effects in humans. Ear Hear. 2006 Dec;27(6):589-607. Review. Erratum in: Ear Hear. 2007 Feb;28(1):129.
Mertes IB, Goodman SS Within- and Across-Subject Variability of Repeated Measurements of Medial Olivocochlear-Induced Changes in Transient-Evoked Otoacoustic Emissions. Ear Hear. 2016 Mar-Apr;37(2):e72-84. doi: 10.1097/AUD.0000000000000244.
Mertes IB, Leek MR Concurrent measures of contralateral suppression of transient-evoked otoacoustic emissions and of auditory steady-state responses. J Acoust Soc Am. 2016 Sep;140(3):2027.
Mertes IB, Wilbanks EC, Leek MR Olivocochlear Efferent Activity Is Associated With the Slope of the Psychometric Function of Speech Recognition in Noise. Ear Hear. 2017 Nov 9. doi: 10.1097/AUD.0000000000000514. [Epub ahead of print]
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
